Clinical trial
Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems
NCT07296263 is registered in ClinicalTrials.gov with Hyperfine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems
- Lead sponsor
- Hyperfine
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 30, 2025
- Completion date
- October 31, 2026
- Enrollment
- 85 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
extra-axial tumors, infection/inflammatory lesions, intra-axial tumors